Enliven Therapeutics, Inc. (ELVN): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001193125-26-449819

Filer

Enliven Therapeutics, Inc. (CIK 1672619)